Mount Sinai, a health system based in New York, has bagged a USD6 million fund for a healthcare technology-based plastic and reconstructive surgery suite. According to the health system, the suite will feature cutting-edge technology and promises to include advanced tools and technology that will revolutionize the way physicians and patients interact and communicate. The technology will be aimed at allowing a more comprehensive and interactive review of pre-surgical planning, better visualization of surgical results following reconstructive surgery, and advanced consultation experience for the patient and the surgeon.
In a statement, Chairman of the Department of Surgery at Sinai’s Icahn School of Medicine, Michael Marin stated that the gift will allow the organization to provide an elevated level of care for patients in a setting that features unrivaled technology and innovative design. Mount Sinai Health System is a hospital network in New York City and was formed back in September 2013 by consolidating the operations of Continuum Health Partners and the Mount Sinai Medical Center. The health system has also introduced a clinical trial of a new imaging device, named Otis Wide Field OCT, for identifying head and neck cancer during surgery. Made by Perimeter Medical Imaging, the device is an ultra-high-resolution imaging system which can detect tumor specimens in real-time surgery. With this device, surgeons can remove all of the cancerous tissue during one procedure, more willingly than waiting for traditional pathology outcomes to come in afterward, which can often lead to additional procedures.
The Mount Sinai Health System has structured around 7 hospital campuses and the Icahn School of Medicine at Mount Sinai. It has recently announced an affiliation with Hasso Plattner Institute to bring Artificial Intelligence and Machine Learning specialists to develop digital health products with real-time prognostic and precautionary capabilities.